Find trials
Search tips

A Study to Evaluate the Prevalence and Impact of Eating Disorders Among Patients with Inflammatory Bowel Disease

Overview

About this study

The purpose of this study is to assess the prevalence of eating disorders; specifically, Avoidant/Restrictive Food Intake Disorder (ARFID) among adult patients in the IBD clinic and compare to the patient population seen in the primary care clinics at Mayo Clinic Florida.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Age between 18 and 75 years old

-Able to read and speak English

Inclusion Criteria:

  • Ages between 18 and 75 years old.
  • Able to read and speak English

Exclusion Criteria: 

  • Pregnancy.
  • Cognitive impairment that makes patient unable to understand and/ or sign informed consent.
  • Patients who are unable to either read or speak English.

 

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Francis Farraye, M.D., M.S.

Contact us for the latest status

Contact information:

Kimberly Robelin M.D.

(904)953-6970

Robelin.Kimberly@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20467541

Mayo Clinic Footer